Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group and…
- SemaglutideFrom $199/mo
- TirzepatideFrom $299/mo
Assume we may earn a commission, at no cost to you. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
- Semaglutide
- From $199/mo (compounded)
- Tirzepatide
- From $299/mo (compounded)
- Coverage
- All 50 states
- Brand-name
- Yes
The scorecard
Medro scored on our six published factors. See the methodology.
What we like
- Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
- LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
- No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
- Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).
The caveats
- Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
- Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
- Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
- Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.
The verdict
Best for: Shoppers who want compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states.
Ranked #66 of 548 providers we have reviewed — for comparison, read the CoreAge Rx review, ranked #1. In the ranking it sits between Intimate Rose at #65, 77/100 above and RestorLife Med at #67, 77/100 below, with the Zera Health write-up the next one down.
A grade C is a ranking, not an instruction to stop looking: the closest rivals to Medro are scored on the identical rubric, so the comparison is like for like. For the wider picture, every review we have published ranks the field on the same six factors. We have also compared it head to head: CoreAge Rx vs Medro goes to CoreAge Rx, 94/100 to 77/100.
Compare Medro
Compare with other providers
The closest reviews to Medro by Verdict Score — the realistic shortlist if you are weighing this one up.
- #46FitFlow— Online access to compounded semaglutide and tirzepatide, with monthly billing or discounted prepaid plans.79/100
- #47Nalena— Nalena is a women-focused, GLP-1-only telehealth platform offering compounded semaglutide and tirzepatide with medication included — no separate membership or visit fees.79/100
- #48Polly— Telehealth weight loss provider selling compounded semaglutide and tirzepatide vials with no membership fee.79/100
- #49Bodybuilding Health+— The Bodybuilding.com fitness brand's new compounded-telehealth arm publishes both ladders in full, and they run in opposite directions: semaglutide steps down from $179/mo to $139/mo on a 12-month prepay, while every tirzepatide bundle costs MORE per month than its $209 month-to-month rate — $286, $250 and $244 — with each badged as a saving. Wrapped in an unusually deep NAD+/sermorelin/peptide menu, but the verdict lands it near the bottom: a brand-new operator (Dynamo Group LLC, launched April 2026) selling compounded, not-FDA-approved meds on an all-sales-final policy, with the pharmacy and provider network unnamed on-site and no LegitScript listing we could verify.76/100
- #50Rylo Health— A small Texas-prescriber startup that prints its promotional rate and its standard rate side by side, which few rows here do.78/100
- #51Big Easy Weight Loss— Physician-led compounded GLP-1 care sold as multiweek packages, with pharmacy-dependent pricing and separate introductory offers.78/100
Pricing, states and verification reflect Medro's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Medro's site. Not medical advice; see our disclosure.